With siRNA-based drugs becoming established as a therapeutic modality, large companies are engaging in the field through deals and acquisitions, cardiovascular metabolic diseases among their targets.

Today, pancreatic cancer ranks second after the cardiovascular system among causes of death. The which is an aggressive type progressing without giving too many symptoms. In addition, factors such as difficulty in early diagnosis, rapid metastasis and non-response to traditional treatments cause a low survival rate this cancer. Therefore, studies are carried out develop alternative diagnosis tr...

Background: It is thought that a limited number of aberrant cancer stem cells (CSCs), which encourage carcinogenesis, tumor metastasis, and treatment resistance, are the cause pancreatic cancer, disease with high mortality rate. Increasing evidence shows CSCs use immunosuppressive properties to avoid immune system identification. In Pancreatic therapeutic consequences relationship between expre...